Comparison of (68)Ga-DOTA-JR11 PET/CT with dosimetric (177)Lu-satoreotide tetraxetan ((177)Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy

PURPOSE: Paired imaging/therapy with radiolabeled somatostatin receptor (SSTR) antagonists is a novel approach in neuroendocrine tumors (NETs). The aim of this study was to compare tumor uptake of (68)Ga-DOTA-JR11 and (177)Lu-satoreotide tetraxetan ((177)Lu-DOTA-JR11) in patients with NETs. METHODS:...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur J Nucl Med Mol Imaging
Autori principali: Krebs, Simone, O’Donoghue, Joseph A., Biegel, Evan, Beattie, Bradley J., Reidy, Diane, Lyashchenko, Serge K., Lewis, Jason S., Bodei, Lisa, Weber, Wolfgang A., Pandit-Taskar, Neeta
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7644587/
https://ncbi.nlm.nih.gov/pubmed/32378020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-020-04832-9
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi